Predicting psychiatric symptoms in methamphetamine psychosis
Part of Mental health clinical trials.
This study looks for patterns in psychiatric symptoms among people who have psychotic symptoms caused by methamphetamine use. You may qualify if you are 18-65, haven't taken psychiatric medication for at least a month, and do not have certain other health conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with psychosis caused by methamphetamine use.
- You have not taken any psychiatric medications for at least one month before joining.
- You are between 18 and 64 years old.
- You do not have high blood pressure, diabetes, kidney disease, rheumatoid arthritis, lupus, heart disease, or serious neurological disorders.
- You do not have another primary psychiatric condition besides methamphetamine-induced psychosis.
- You do not have an alcohol use disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares people who have psychosis from methamphetamine and also use cannabis with those who only have methamphetamine-induced psychosis. It aims to understand how cannabis may affect their symptoms.
This study looks at the electrical activity of the heart (ECG) in people who use methamphetamine, including those who develop psychosis from it. It compares them to healthy volunteers to see if methamphetamine affects heart function.
This study looks at two blood proteins (LRFN5 and OLFM4) in people with methamphetamine use disorder or methamphetamine-induced psychosis, compared to healthy controls. Results may help understand the biology of these conditions.
This study observes patients with psychosis to help tell if it is caused by schizophrenia or by methamphetamine use, so doctors can offer the right treatment.
This trial tests whether a psychedelic drug called psilocybin can help people cut down or stop using methamphetamine. You'll take the drug in a supervised setting and get support to aim for full abstinence.
This study uses brain scans and a medication called methylphenidate (Ritalin) to understand how the brain chemical dopamine works in people at early risk for psychosis. It may help researchers find better ways to predict and treat psychosis.
Hear when a new Methamphetamine Induced Psychosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.